Myeloid-derived suppressor cells: natural regulators for transplant tolerance.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Human Immunology

• Publication date

  2010-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.humimm.2010.08.001PMID 20705113PMCID PMC3713408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice.

  2010cited by this paper
• 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.

  2010cited by this paper
• CD49d Is a New Marker for Distinct Myeloid-Derived Suppressor Cell Subpopulations in Mice

  2010cited by this paper
• Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.

  2010cited by this paper
• Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.

  2010cited by this paper
• Development of Monocytes, Macrophages, and Dendritic Cells

  2010cited by this paper
• Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

  2010cited by this paper
• Myeloid-derived suppressor cell heterogeneity and subset definition.

  2010cited by this paper
• Development and Function of Myeloid‐Derived Suppressor Cells Generated From Mouse Embryonic and Hematopoietic Stem Cells

  2010cited by this paper
• CP-690550, a JAK3 inhibitor as an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders.

  2009cited by this paper
• Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-β11

  2009cited by this paper
• Endotoxin‐Induced Myeloid‐Derived Suppressor Cells Inhibit Alloimmune Responses via Heme Oxygenase‐1

  2009cited by this paper
• Peptide inhibitors of transforming growth factor‐β enhance the efficacy of antitumor immunotherapy

  2009cited by this paper
• IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients1

  2009cited by this paper
• Therapeutic targeting of myeloid-derived suppressor cells.

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice.

  2009cited by this paper
• Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

  2009cited by this paper
• The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.

  2009cited by this paper
• Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.

  2009cited by this paper
• Monocyte dependent regulation of autoimmune inflammation.

  2009cited by this paper
• Myeloid‐derived suppressor cell activation by combined LPS and IFN‐γ treatment impairs DC development

  2009cited by this paper
• Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSF

  2009cited by this paper
• Myeloid-derived suppressor cells: A novel therapeutic target

  2009cited by this paper
• STATs in cancer inflammation and immunity: a leading role for STAT3

  2009cited by this paper
• Myeloid-Derived Suppressor Cells Accumulate in Kidney Allograft Tolerance and Specifically Suppress Effector T Cell Expansion1

  2008cited by this paper
• Human Inhibitory Receptor Immunoglobulin-Like Transcript 2 Amplifies CD11b+Gr1+ Myeloid-Derived Suppressor Cells That Promote Long-Term Survival of Allografts

  2008cited by this paper
• Tumor escape mechanism governed by myeloid-derived suppressor cells.

  2008cited by this paper
• Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations.

  2008cited by this paper
• Tumor‐infiltrating myeloid‐derived suppressor cells are pleiotropic‐inflamed monocytes/macrophages that bear M1‐ and M2‐type characteristics

  2008cited by this paper
• Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.

  2008cited by this paper
• Immune regulation by non‐lymphoid cells in transplantation

  2008influential reference
• Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients

  2008cited by this paper
• Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

  2008cited by this paper
• Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1

  2008cited by this paper
• A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

  2008cited by this paper
• Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells

  2008cited by this paper
• Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function.

  2008cited by this paper
• Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.

  2008cited by this paper
• Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives

  2008influential reference
• Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells1

  2008cited by this paper
• Analysis of splenic Gr‐1int immature myeloid cells in tumor‐bearing mice

  2008cited by this paper
• Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.

  2007cited by this paper
• Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

  2007cited by this paper
• Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells.

  2007cited by this paper
• MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis

  2007cited by this paper
• S100 proteins expressed in phagocytes: a novel group of damage‐associated molecular pattern molecules

  2007cited by this paper
• Mycobacteria‐induced Gr‐1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion

  2007cited by this paper
• Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host.

  2007influential reference
• L-arginine availability regulates T-lymphocyte cell-cycle progression.

  2007cited by this paper
• Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

  2007cited by this paper
• Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

  2006cited by this paper
• Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

  2006cited by this paper
• Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

  2006cited by this paper
• CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.

  2006cited by this paper
• Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts

  2006cited by this paper
• Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.

  2005influential reference
• Impairment of the activity of the xenobiotic‐metabolizing enzymes arylamine N‐acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells

  2005cited by this paper
• Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion.

  2005cited by this paper
• Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway.

  2005cited by this paper
• Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

  2005cited by this paper
• Tumor-Associated CD8+ T Cell Tolerance Induced by Bone Marrow-Derived Immature Myeloid Cells1

  2005cited by this paper
• Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro

  2005cited by this paper
• Combined treatment of glatiramer acetate and low doses of immunosuppressive drugs is effective in the prevention of graft rejection.

  2005cited by this paper
• Cytokine Expanded Myeloid Precursors Function as Regulatory Antigen-Presenting Cells and Promote Tolerance through IL-10-Producing Regulatory T Cells1

  2005cited by this paper
• Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3

  2004cited by this paper
• Reactive oxygen species production by blood neutrophils of patients with laryngeal carcinoma and antioxidative enzyme activity in their blood

  2004cited by this paper
• Role of Immature Myeloid Gr-1+ Cells in the Development of Antitumor Immunity

  2004cited by this paper
• High-Dose Granulocyte-Macrophage Colony-Stimulating Factor-Producing Vaccines Impair the Immune Response through the Recruitment of Myeloid Suppressor Cells

  2004cited by this paper
• Both Expansion of Regulatory GR1+ CD11b+ Myeloid Cells and Anergy of T Lymphocytes Participate in Hyporesponsiveness of the Lung-Associated Immune System during Acute Toxoplasmosis

  2004cited by this paper
• Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+ )immature myeloid suppressor cells.

  2002cited by this paper
• CD80+Gr-1+ Myeloid Cells Inhibit Development of Antifungal Th1 Immunity in Mice with Candidiasis1

  2002cited by this paper
• Retinoic acid receptor antagonism in vivo expands the numbers of precursor cells during granulopoiesis

  2002cited by this paper
• Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite

  2002cited by this paper
• Reactive Oxygen Species as Intracellular Messengers During Cell Growth and Differentiation

  2001cited by this paper
• Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

  2001cited by this paper
• Cutting Edge: Stat6-Dependent Substrate Depletion Regulates Nitric Oxide Production1

  2001influential reference
• The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.

  1999cited by this paper
• Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo.

  1998cited by this paper
• Transforming Growth Factor-␤ Production and Myeloid Cells Are an Effector Mechanism through Which Cd1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance: Abrogation Prevents Tumor Recurrence

  year unknowncited by this paper

• Use of regulatory cells for achieving functional tolerance of pig heart xenotransplants in humans: a literature review

  2025cites this paper
• A novel LncRNA risk model for disulfidptosis-related prognosis prediction and response to chemotherapy in acute myeloid leukemia

  2025cites this paper
• GM-CSF-mediated inducement of bone marrow MDSCs by TSA and effect on survival of graft in mice

  2022cites this paper
• Multi‐Mode Antibacterial Strategies Enabled by Gene‐Transfection and Immunomodulatory Nanoparticles in 3D‐Printed Scaffolds for Synergistic Exogenous and Endogenous Treatment of Infections

  2022cites this paper
• TGF-β Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression

  2022cites this paper
• Aging Affects the Role of Myeloid-Derived Suppressor Cells in Alloimmunity

  2022cites this paper
• Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases

  2021cites this paper
• Th2 cells lacking T-bet suppress naive and memory T cell responses via IL-10

  2021cites this paper
• Myeloid-derived suppressor cells in transplantation tolerance induction.

  2020cites this paper
• T regulatory cell therapy in preclinical and clinical pancreatic islet transplantation

  2020cites this paper
• Emerging Role of Myeloid-derived Suppressor Cells in the Biology of Transplantation Tolerance

  2020cites this paper
• Strategies to achieve immune tolerance in allogeneic solid organ transplantation.

  2020cites this paper
• Intravascular innate immune cells reprogrammed via intravenous nanoparticles to promote functional recovery after spinal cord injury

  2019cites this paper
• Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand?

  2019cites this paper
• Relationship of Transforming Growth Factor-βl and Arginase-1 Levels with Long-term Survival after Kidney Transplantation

  2018cites this paper
• Immunological biomarkers of tolerance in human kidney transplantation: An updated literature review

  2018cites this paper
• Dexamethasone-Induced Myeloid-Derived Suppressor Cells Prolong Allo Cardiac Graft Survival through iNOS- and Glucocorticoid Receptor-Dependent Mechanism

  2018cites this paper
• Myeloid-Derived Suppressor Cells Ameliorate Cyclosporine A–Induced Hypertension in Mice

  2018cites this paper
• A gene-based approach to experimental heart transplant rejection

  2018cites this paper
• C-C Chemokine Receptor Type 2–Dependent Migration of Myeloid-Derived Suppressor Cells in Protection of Islet Transplants

  2017cites this paper
• Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses

  2017cites this paper
• Immunosuppressive Therapy in Heart Transplantation

  2017cites this paper
• Efferocytosis and Outside-In Signaling by Cardiac Phagocytes. Links to Repair, Cellular Programming, and Intercellular Crosstalk in Heart

  2017cites this paper
• Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.

  2017cites this paper
• The blockage of Notch signalling promoted the generation of polymorphonuclear myeloid-derived suppressor cells with lower immunosuppression.

  2016cites this paper
• In Vivo Mobilization and Functional Characterization of Nonhuman Primate Monocytic Myeloid‐Derived Suppressor Cells

  2016cites this paper
• Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE2 Pathway

  2016cites this paper
• Immunosuppressive CD11b+Ly6Chi monocytes in pristane‐induced lupus mouse model

  2016cites this paper
• New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation.

  2016cites this paper
• Immunobiology of Transplantation

  2016cites this paper
• The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity

  2015cites this paper
• G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease

  2015cites this paper
• Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes.

  2015cites this paper
• Etudes de diverses sous-populations de cellules dentritiques au cours des cancers et maladies auto-immunes

  2015cites this paper
• Mechanisms of Immune Regulation

  2014cites this paper
• myeloid-derived suppressor cells The role of complement component 3 (C3) in differentiation of

  2014cites this paper
• Cotransplantation With Myeloid-Derived Suppressor Cells Protects Cell Transplants: A Crucial Role of Inducible Nitric Oxide Synthase

  2014cites this paper
• Regulatory Myeloid Cells in Transplantation

  2014cites this paper
• Stable immunosuppression under low-dose Tacrolimus monotherapy is dependent upon immunological regulation

  2014influential citation
• Therapeutic Inflammatory Monocyte Modulation Using Immune-Modifying Microparticles

  2014cites this paper
• Cell-Based Modulation of Autoimmune Responses in Multiple Sclerosis and Experimental Autoimmmune Encephalomyelitis: Therapeutic Implications

  2014cites this paper
• Transplantation tolerance.

  2013cites this paper
• MANIPULATION OF REGULATORY MYELOID CELL DIFFERENTIATION AND FUNCTION AND ITS THERAPEUTIC IMPLICATIONS

  2013cites this paper
• Regulatory T-cells for immunotherapy

  2013influential citation
• The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells.

  2013cites this paper
• Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs

  2012cites this paper
• Control of Transplant Tolerance and Intragraft Regulatory T Cell Localization by Myeloid-Derived Suppressor Cells and CCL5

  2012cites this paper
• Regulatory immune cells in transplantation

  2012cites this paper
• Generation of myeloid-derived suppressor cells using prostaglandin E2

  2012cites this paper
• Regulation of the Alloimmune Response

  2012cites this paper
• HDAC inhibitor therapy in autoimmunity and transplantation

  2012cites this paper
• Crucial Role of Granulocytic Myeloid-Derived Suppressor Cells in the Regulation of Central Nervous System Autoimmune Disease

  2012cites this paper
• Translating tolerogenic therapies to the clinic – where do we stand?

  2012cites this paper
• Identification of Myeloid Derived Suppressor Cells in Tumor Bearing Dogs

  2012cites this paper
• Myeloid-Derived Suppressor Cells and CCL5 Intragraft Regulatory T Cell Localization by Control of Transplant Tolerance and

  2012cites this paper
• What's New, What's Hot in Solid Organ Transplantation? Summary of the American Transplant Congress 2011

  2011cites this paper
• Rationale for HDAC inhibitor therapy in autoimmunity and transplantation.

  2011cites this paper
• This information is current as Autoimmune Disease Regulation of Central Nervous System Myeloid-Derived Suppressor Cells in the Crucial Role of Granulocytic

  2011cites this paper
• Stromal cell-based immunotherapy in transplantation.

  2011cites this paper
• Inhibition sélective de la costimulation CD28-CD80/86 en transplantation : mécanismes d'action des cellules régulatrices

  2011cites this paper
• Immunobiology of Transplantation: Impact on Targets for Large and Small Molecules

  2011cites this paper
• Interleukin‐33 prolongs allograft survival during chronic cardiac rejection

  2011cites this paper
• Engineering human single-chain T cell receptors

  2010cites this paper
• Approaches to the Induction of Tolerance

  2008cites this paper
• Cognitive Performance and Grey Matter Density in Psychosis: Functional Relevance of a Structural Endophenotype

  2008cites this paper